Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(drug repurposing). Showing records 1 – 30 of 56 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

Levels

Country

▼ Search Limiters


University of Texas – Austin

1. -1028-134X. Teaching an old drug new tricks : exploring formulation and route of delivery methods for repurposing drugs to treat CNS diseases.

Degree: PhD, Pharmaceutical Sciences, 2018, University of Texas – Austin

 A major barrier to the treatment of central nervous system delivery is the ability to target drug delivery to the brain. The brain is protected… (more)

Subjects/Keywords: Nasal; Drug delivery; Repurposing; Glioblastoma; Personalized medicine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

-1028-134X. (2018). Teaching an old drug new tricks : exploring formulation and route of delivery methods for repurposing drugs to treat CNS diseases. (Doctoral Dissertation). University of Texas – Austin. Retrieved from http://dx.doi.org/10.26153/tsw/11671

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Chicago Manual of Style (16th Edition):

-1028-134X. “Teaching an old drug new tricks : exploring formulation and route of delivery methods for repurposing drugs to treat CNS diseases.” 2018. Doctoral Dissertation, University of Texas – Austin. Accessed April 14, 2021. http://dx.doi.org/10.26153/tsw/11671.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

MLA Handbook (7th Edition):

-1028-134X. “Teaching an old drug new tricks : exploring formulation and route of delivery methods for repurposing drugs to treat CNS diseases.” 2018. Web. 14 Apr 2021.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Vancouver:

-1028-134X. Teaching an old drug new tricks : exploring formulation and route of delivery methods for repurposing drugs to treat CNS diseases. [Internet] [Doctoral dissertation]. University of Texas – Austin; 2018. [cited 2021 Apr 14]. Available from: http://dx.doi.org/10.26153/tsw/11671.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Council of Science Editors:

-1028-134X. Teaching an old drug new tricks : exploring formulation and route of delivery methods for repurposing drugs to treat CNS diseases. [Doctoral Dissertation]. University of Texas – Austin; 2018. Available from: http://dx.doi.org/10.26153/tsw/11671

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete


University of Utah

2. Gibson, Christopher C. Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting.

Degree: PhD, Bioengineering, 2014, University of Utah

 Destabilization of the endothelial monolayer lining blood vessels has profound consequences onorganismal homeostasis. Vascular instability plays a well-known role in the pathophysiology of diseasesfrom sepsis… (more)

Subjects/Keywords: Drug discovery; Drug repurposing; Endothelium; High-content; Screening; Stroke

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gibson, C. C. (2014). Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting. (Doctoral Dissertation). University of Utah. Retrieved from http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/3501/rec/1282

Chicago Manual of Style (16th Edition):

Gibson, Christopher C. “Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting.” 2014. Doctoral Dissertation, University of Utah. Accessed April 14, 2021. http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/3501/rec/1282.

MLA Handbook (7th Edition):

Gibson, Christopher C. “Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting.” 2014. Web. 14 Apr 2021.

Vancouver:

Gibson CC. Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting. [Internet] [Doctoral dissertation]. University of Utah; 2014. [cited 2021 Apr 14]. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/3501/rec/1282.

Council of Science Editors:

Gibson CC. Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting. [Doctoral Dissertation]. University of Utah; 2014. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/3501/rec/1282


University of Toronto

3. Wilson, Taylor Marie. Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme.

Degree: 2020, University of Toronto

Glioblastoma multiforme is an aggressive brain tumour characterized by poor prognosis, with overall patient survival rates averaging less than 15 months. Current treatment methods display… (more)

Subjects/Keywords: Cancer; Chemotherapy; Cholesterol; Drug Discovery; Drug Repurposing; Glioblastoma; 0379

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wilson, T. M. (2020). Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/103133

Chicago Manual of Style (16th Edition):

Wilson, Taylor Marie. “Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme.” 2020. Masters Thesis, University of Toronto. Accessed April 14, 2021. http://hdl.handle.net/1807/103133.

MLA Handbook (7th Edition):

Wilson, Taylor Marie. “Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme.” 2020. Web. 14 Apr 2021.

Vancouver:

Wilson TM. Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme. [Internet] [Masters thesis]. University of Toronto; 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1807/103133.

Council of Science Editors:

Wilson TM. Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme. [Masters Thesis]. University of Toronto; 2020. Available from: http://hdl.handle.net/1807/103133


Virginia Commonwealth University

4. Wang, Chen. High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome.

Degree: PhD, Computer Science, 2018, Virginia Commonwealth University

  Drugs exert their (therapeutic) effects via molecular-level interactions with proteins and other biomolecules. Computational prediction of drug-protein interactions plays a significant role in the… (more)

Subjects/Keywords: drug-protein interactions; computational prediction; drug target database; drug repurposing; drug side-effects; Bioinformatics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, C. (2018). High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/E2X0-B462 ; https://scholarscompass.vcu.edu/etd/5509

Chicago Manual of Style (16th Edition):

Wang, Chen. “High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome.” 2018. Doctoral Dissertation, Virginia Commonwealth University. Accessed April 14, 2021. https://doi.org/10.25772/E2X0-B462 ; https://scholarscompass.vcu.edu/etd/5509.

MLA Handbook (7th Edition):

Wang, Chen. “High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome.” 2018. Web. 14 Apr 2021.

Vancouver:

Wang C. High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2018. [cited 2021 Apr 14]. Available from: https://doi.org/10.25772/E2X0-B462 ; https://scholarscompass.vcu.edu/etd/5509.

Council of Science Editors:

Wang C. High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome. [Doctoral Dissertation]. Virginia Commonwealth University; 2018. Available from: https://doi.org/10.25772/E2X0-B462 ; https://scholarscompass.vcu.edu/etd/5509


University of Rochester

5. Butts, Arielle Marie (1989 - ). Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents.

Degree: PhD, 2014, University of Rochester

 Cryptococcus neoformans is an opportunistic human fungal pathogen that is capable of causing life-threatening infections. These infections generally occur in individuals with compromised immunity such… (more)

Subjects/Keywords: Antifungal; Cryptococcus; Drug discovery; Mode of action; Repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Butts, A. M. (. -. ). (2014). Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents. (Doctoral Dissertation). University of Rochester. Retrieved from http://hdl.handle.net/1802/28300

Chicago Manual of Style (16th Edition):

Butts, Arielle Marie (1989 - ). “Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents.” 2014. Doctoral Dissertation, University of Rochester. Accessed April 14, 2021. http://hdl.handle.net/1802/28300.

MLA Handbook (7th Edition):

Butts, Arielle Marie (1989 - ). “Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents.” 2014. Web. 14 Apr 2021.

Vancouver:

Butts AM(-). Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents. [Internet] [Doctoral dissertation]. University of Rochester; 2014. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1802/28300.

Council of Science Editors:

Butts AM(-). Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents. [Doctoral Dissertation]. University of Rochester; 2014. Available from: http://hdl.handle.net/1802/28300


Texas A&M University

6. Sundararajan Venkatasubramani, Priyadharshini. Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data.

Degree: PhD, Electrical Engineering, 2017, Texas A&M University

 Scientific and technological advancements over the years have made curing, preventing or managing all diseases, a goal that seems to be within reach. The approach… (more)

Subjects/Keywords: plant pathogen interactions; metformin; RNA sequencing; drug repurposing; bayesian networks

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sundararajan Venkatasubramani, P. (2017). Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data. (Doctoral Dissertation). Texas A&M University. Retrieved from http://hdl.handle.net/1969.1/165919

Chicago Manual of Style (16th Edition):

Sundararajan Venkatasubramani, Priyadharshini. “Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data.” 2017. Doctoral Dissertation, Texas A&M University. Accessed April 14, 2021. http://hdl.handle.net/1969.1/165919.

MLA Handbook (7th Edition):

Sundararajan Venkatasubramani, Priyadharshini. “Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data.” 2017. Web. 14 Apr 2021.

Vancouver:

Sundararajan Venkatasubramani P. Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data. [Internet] [Doctoral dissertation]. Texas A&M University; 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1969.1/165919.

Council of Science Editors:

Sundararajan Venkatasubramani P. Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data. [Doctoral Dissertation]. Texas A&M University; 2017. Available from: http://hdl.handle.net/1969.1/165919


University of Toronto

7. Yun, Junghwa. Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens.

Degree: 2017, University of Toronto

Phosphoenolypyruvate carboxykinase (PEPCK) is the rate limiting enzyme in hepatic gluconeogenesis, which produces glucose from pyruvate to maintain circulating glucose level according to the bodyâ… (more)

Subjects/Keywords: Diabetes; Drug repurposing; Gluconeogenesis; Pck1; Pyruvate tolerance test; Zebrafish; 0719

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yun, J. (2017). Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/97184

Chicago Manual of Style (16th Edition):

Yun, Junghwa. “Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens.” 2017. Masters Thesis, University of Toronto. Accessed April 14, 2021. http://hdl.handle.net/1807/97184.

MLA Handbook (7th Edition):

Yun, Junghwa. “Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens.” 2017. Web. 14 Apr 2021.

Vancouver:

Yun J. Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1807/97184.

Council of Science Editors:

Yun J. Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/97184


University of Cambridge

8. Donertas, Handan Melike. Computational studies on ageing and age-related diseases.

Degree: PhD, 2020, University of Cambridge

 Age is the major risk factor for a variety of non-communicable diseases. As life expectancy increases, ageing poses significant challenges to the individual, society, and… (more)

Subjects/Keywords: ageing; age-related diseases; drug repurposing; transcriptomics; GWAS

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Donertas, H. M. (2020). Computational studies on ageing and age-related diseases. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.58440 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.818164

Chicago Manual of Style (16th Edition):

Donertas, Handan Melike. “Computational studies on ageing and age-related diseases.” 2020. Doctoral Dissertation, University of Cambridge. Accessed April 14, 2021. https://doi.org/10.17863/CAM.58440 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.818164.

MLA Handbook (7th Edition):

Donertas, Handan Melike. “Computational studies on ageing and age-related diseases.” 2020. Web. 14 Apr 2021.

Vancouver:

Donertas HM. Computational studies on ageing and age-related diseases. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Apr 14]. Available from: https://doi.org/10.17863/CAM.58440 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.818164.

Council of Science Editors:

Donertas HM. Computational studies on ageing and age-related diseases. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://doi.org/10.17863/CAM.58440 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.818164


Leiden University

9. Frouws, M.A. Renewing clinical applications for commonly used medications in gastrointestinal cancer.

Degree: 2017, Leiden University

  <table width="100%"><tbody><tr><td> This thesis tried to unravel the epidemiological background of the current evidence on the effect of aspirin on gastrointestinal cancer. </td></tr></tbody></table> Advisors/Committee… (more)

Subjects/Keywords: Aspirine; Drug repurposing; Gastrointestinal cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Frouws, M. A. (2017). Renewing clinical applications for commonly used medications in gastrointestinal cancer. (Doctoral Dissertation). Leiden University. Retrieved from http://hdl.handle.net/1887/55950

Chicago Manual of Style (16th Edition):

Frouws, M A. “Renewing clinical applications for commonly used medications in gastrointestinal cancer.” 2017. Doctoral Dissertation, Leiden University. Accessed April 14, 2021. http://hdl.handle.net/1887/55950.

MLA Handbook (7th Edition):

Frouws, M A. “Renewing clinical applications for commonly used medications in gastrointestinal cancer.” 2017. Web. 14 Apr 2021.

Vancouver:

Frouws MA. Renewing clinical applications for commonly used medications in gastrointestinal cancer. [Internet] [Doctoral dissertation]. Leiden University; 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1887/55950.

Council of Science Editors:

Frouws MA. Renewing clinical applications for commonly used medications in gastrointestinal cancer. [Doctoral Dissertation]. Leiden University; 2017. Available from: http://hdl.handle.net/1887/55950


University of Cambridge

10. Donertas, Handan Melike. Computational studies on ageing and age-related diseases.

Degree: PhD, 2020, University of Cambridge

 Age is the major risk factor for a variety of non-communicable diseases. As life expectancy increases, ageing poses significant challenges to the individual, society, and… (more)

Subjects/Keywords: ageing; age-related diseases; drug repurposing; transcriptomics; GWAS

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Donertas, H. M. (2020). Computational studies on ageing and age-related diseases. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/311350

Chicago Manual of Style (16th Edition):

Donertas, Handan Melike. “Computational studies on ageing and age-related diseases.” 2020. Doctoral Dissertation, University of Cambridge. Accessed April 14, 2021. https://www.repository.cam.ac.uk/handle/1810/311350.

MLA Handbook (7th Edition):

Donertas, Handan Melike. “Computational studies on ageing and age-related diseases.” 2020. Web. 14 Apr 2021.

Vancouver:

Donertas HM. Computational studies on ageing and age-related diseases. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Apr 14]. Available from: https://www.repository.cam.ac.uk/handle/1810/311350.

Council of Science Editors:

Donertas HM. Computational studies on ageing and age-related diseases. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://www.repository.cam.ac.uk/handle/1810/311350


University of Manchester

11. Taylor, Jessica Tanya. High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme.

Degree: 2019, University of Manchester

 Glioblastoma Multiforme is the most common adult primary brain tumour, with median survival rates of around 15 months. The aggressive and heterogeneous nature of this… (more)

Subjects/Keywords: glioblastoma; neuro oncology; drug repurposing; personalised medicine; drug screening; mouse models; brain tumours; cancer research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Taylor, J. T. (2019). High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:319176

Chicago Manual of Style (16th Edition):

Taylor, Jessica Tanya. “High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme.” 2019. Doctoral Dissertation, University of Manchester. Accessed April 14, 2021. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:319176.

MLA Handbook (7th Edition):

Taylor, Jessica Tanya. “High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme.” 2019. Web. 14 Apr 2021.

Vancouver:

Taylor JT. High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme. [Internet] [Doctoral dissertation]. University of Manchester; 2019. [cited 2021 Apr 14]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:319176.

Council of Science Editors:

Taylor JT. High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme. [Doctoral Dissertation]. University of Manchester; 2019. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:319176


University of Melbourne

12. Hameed, Pathima Nusrath. In silico methods for drug repositioning and drug-drug interaction prediction.

Degree: 2018, University of Melbourne

Drug repositioning and drug-drug interaction (DDI) prediction are two fundamental applications having a large impact on drug development and clinical care. Drug repositioning aims to… (more)

Subjects/Keywords: drug repurposing; biomedical informatics; DDI prediction; drug-target prediction; heterogeneous data integration; cluster evaluation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hameed, P. N. (2018). In silico methods for drug repositioning and drug-drug interaction prediction. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/219484

Chicago Manual of Style (16th Edition):

Hameed, Pathima Nusrath. “In silico methods for drug repositioning and drug-drug interaction prediction.” 2018. Doctoral Dissertation, University of Melbourne. Accessed April 14, 2021. http://hdl.handle.net/11343/219484.

MLA Handbook (7th Edition):

Hameed, Pathima Nusrath. “In silico methods for drug repositioning and drug-drug interaction prediction.” 2018. Web. 14 Apr 2021.

Vancouver:

Hameed PN. In silico methods for drug repositioning and drug-drug interaction prediction. [Internet] [Doctoral dissertation]. University of Melbourne; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/11343/219484.

Council of Science Editors:

Hameed PN. In silico methods for drug repositioning and drug-drug interaction prediction. [Doctoral Dissertation]. University of Melbourne; 2018. Available from: http://hdl.handle.net/11343/219484


University of Manchester

13. Taylor, Jessica. High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme.

Degree: PhD, 2019, University of Manchester

 Glioblastoma Multiforme is the most common adult primary brain tumour, with median survival rates of around 15 months. The aggressive and heterogeneous nature of this… (more)

Subjects/Keywords: mouse models; cancer research; brain tumours; drug screening; personalised medicine; drug repurposing; neuro oncology; glioblastoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Taylor, J. (2019). High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/high-throughput-screening-of-patient-specific-tumour-cells-towards-personalised-treatment-in-recurrent-glioblastoma-multiforme(f4b3043c-faf0-4298-9b9f-2adb6a9577b6).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.809321

Chicago Manual of Style (16th Edition):

Taylor, Jessica. “High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme.” 2019. Doctoral Dissertation, University of Manchester. Accessed April 14, 2021. https://www.research.manchester.ac.uk/portal/en/theses/high-throughput-screening-of-patient-specific-tumour-cells-towards-personalised-treatment-in-recurrent-glioblastoma-multiforme(f4b3043c-faf0-4298-9b9f-2adb6a9577b6).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.809321.

MLA Handbook (7th Edition):

Taylor, Jessica. “High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme.” 2019. Web. 14 Apr 2021.

Vancouver:

Taylor J. High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme. [Internet] [Doctoral dissertation]. University of Manchester; 2019. [cited 2021 Apr 14]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/high-throughput-screening-of-patient-specific-tumour-cells-towards-personalised-treatment-in-recurrent-glioblastoma-multiforme(f4b3043c-faf0-4298-9b9f-2adb6a9577b6).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.809321.

Council of Science Editors:

Taylor J. High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme. [Doctoral Dissertation]. University of Manchester; 2019. Available from: https://www.research.manchester.ac.uk/portal/en/theses/high-throughput-screening-of-patient-specific-tumour-cells-towards-personalised-treatment-in-recurrent-glioblastoma-multiforme(f4b3043c-faf0-4298-9b9f-2adb6a9577b6).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.809321

14. Dai, Yuheng. The Commercilazation of a Noval Antithrombotic Drug.

Degree: MSs, Biology, 2018, Case Western Reserve University School of Graduate Studies

 Thrombotic events are the main cause of morbidity and mortality in developed countries, and continue to be an important focus for new therapeutic research. A… (more)

Subjects/Keywords: Biology; Medicine; Thymidine phosphorylase, platelet, thrombosis, anti-platelet therapy, commercialization, drug repositioning, drug repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dai, Y. (2018). The Commercilazation of a Noval Antithrombotic Drug. (Masters Thesis). Case Western Reserve University School of Graduate Studies. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=case1505303242046038

Chicago Manual of Style (16th Edition):

Dai, Yuheng. “The Commercilazation of a Noval Antithrombotic Drug.” 2018. Masters Thesis, Case Western Reserve University School of Graduate Studies. Accessed April 14, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=case1505303242046038.

MLA Handbook (7th Edition):

Dai, Yuheng. “The Commercilazation of a Noval Antithrombotic Drug.” 2018. Web. 14 Apr 2021.

Vancouver:

Dai Y. The Commercilazation of a Noval Antithrombotic Drug. [Internet] [Masters thesis]. Case Western Reserve University School of Graduate Studies; 2018. [cited 2021 Apr 14]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1505303242046038.

Council of Science Editors:

Dai Y. The Commercilazation of a Noval Antithrombotic Drug. [Masters Thesis]. Case Western Reserve University School of Graduate Studies; 2018. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1505303242046038


University of Michigan

15. Truchan, Nathan. The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs.

Degree: PhD, Pharmaceutical Sciences, 2020, University of Michigan

 Triple negative breast cancer (TNBC) is known to be a highly heterogeneous disease and therefore more difficult to treat compared to other subtypes of breast… (more)

Subjects/Keywords: Triple Negative Breast Cancer; Cancer Stem Cells; Drug Repurposing; Heterogeneity; Science (General); Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Truchan, N. (2020). The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/155328

Chicago Manual of Style (16th Edition):

Truchan, Nathan. “The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs.” 2020. Doctoral Dissertation, University of Michigan. Accessed April 14, 2021. http://hdl.handle.net/2027.42/155328.

MLA Handbook (7th Edition):

Truchan, Nathan. “The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs.” 2020. Web. 14 Apr 2021.

Vancouver:

Truchan N. The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs. [Internet] [Doctoral dissertation]. University of Michigan; 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2027.42/155328.

Council of Science Editors:

Truchan N. The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs. [Doctoral Dissertation]. University of Michigan; 2020. Available from: http://hdl.handle.net/2027.42/155328


University of the Western Cape

16. Omoruyi, Sylvester Ifeanyi. Investigating the anti-cancer activity of novel phenothiazines in glioblastoma .

Degree: 2018, University of the Western Cape

 Glioblastoma multiforme (GBM) remains the most malignant of all primary adult brain tumours. It is a highly invasive and vascularized neoplasm with limited treatment options… (more)

Subjects/Keywords: Drug repurposing; Phenothiazines; Chemotherapy; Anti-cancer agents; Cancer; Brain tumours; Glioblastoma; DNA damage; Apoptosis; Autophagy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Omoruyi, S. I. (2018). Investigating the anti-cancer activity of novel phenothiazines in glioblastoma . (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/6329

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Omoruyi, Sylvester Ifeanyi. “Investigating the anti-cancer activity of novel phenothiazines in glioblastoma .” 2018. Thesis, University of the Western Cape. Accessed April 14, 2021. http://hdl.handle.net/11394/6329.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Omoruyi, Sylvester Ifeanyi. “Investigating the anti-cancer activity of novel phenothiazines in glioblastoma .” 2018. Web. 14 Apr 2021.

Vancouver:

Omoruyi SI. Investigating the anti-cancer activity of novel phenothiazines in glioblastoma . [Internet] [Thesis]. University of the Western Cape; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/11394/6329.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Omoruyi SI. Investigating the anti-cancer activity of novel phenothiazines in glioblastoma . [Thesis]. University of the Western Cape; 2018. Available from: http://hdl.handle.net/11394/6329

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. Hadwen, Jeremiah. Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation .

Degree: 2018, University of Ottawa

 Rare diseases caused by single-gene mutations affect almost one million Canadians. According to the Online Mendelian Inheritance in Man database, ~4,500 rare monogenic diseases have… (more)

Subjects/Keywords: Neurogenetics; Rare diseases; Drug repurposing

…Transcriptional drug repurposing to treat rare neurogenetic diseases 1 Rare monogenic diseases Rare… …view. Drug repurposing Repurposing clinically-tested small molecules and biologics has… …clinical effect, are prime targets for drug repurposing. Compared to new drug development, the… …early instances of drug repurposing occurred serendipitously because of unanticipated side… …effects. As drug repurposing research has gained momentum, more structured and efficient… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hadwen, J. (2018). Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/37581

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hadwen, Jeremiah. “Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation .” 2018. Thesis, University of Ottawa. Accessed April 14, 2021. http://hdl.handle.net/10393/37581.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hadwen, Jeremiah. “Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation .” 2018. Web. 14 Apr 2021.

Vancouver:

Hadwen J. Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation . [Internet] [Thesis]. University of Ottawa; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10393/37581.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hadwen J. Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation . [Thesis]. University of Ottawa; 2018. Available from: http://hdl.handle.net/10393/37581

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. ADLER, NIKOLETTA. Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods.

Degree: School of Biochemistry & Immunology. Discipline of Biochemistry, 2018, Trinity College Dublin

 Human African Trypanosomiasis is a neglected parasitic disease caused by Trypanosoma brucei, which if left untreated eventually leads to coma and death. With no successful… (more)

Subjects/Keywords: anti-trypnosomal; cysteine protease inhibitor; drug repurposing; Fingolimod; S1P; SPK-843; Amphotericin B

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

ADLER, N. (2018). Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods. (Thesis). Trinity College Dublin. Retrieved from http://hdl.handle.net/2262/82830

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

ADLER, NIKOLETTA. “Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods.” 2018. Thesis, Trinity College Dublin. Accessed April 14, 2021. http://hdl.handle.net/2262/82830.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

ADLER, NIKOLETTA. “Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods.” 2018. Web. 14 Apr 2021.

Vancouver:

ADLER N. Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods. [Internet] [Thesis]. Trinity College Dublin; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2262/82830.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

ADLER N. Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods. [Thesis]. Trinity College Dublin; 2018. Available from: http://hdl.handle.net/2262/82830

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Notre Dame

19. William T. Barker. Small Molecules That Synergize with Colistin</h1>.

Degree: Chemistry and Biochemistry, 2020, University of Notre Dame

  Antibiotic resistant bacteria pose an existential threat to the modern healthcare system. The degree and severity of antibiotic resistance that is clinically observed continually… (more)

Subjects/Keywords: Polymyxins; Organic Chemistry; Small Molecules; Antibiotic Resistant Bacteria; Colistin; Adjuvants; Drug Repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Barker, W. T. (2020). Small Molecules That Synergize with Colistin</h1>. (Thesis). University of Notre Dame. Retrieved from https://curate.nd.edu/show/db78tb12q6h

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Barker, William T.. “Small Molecules That Synergize with Colistin</h1>.” 2020. Thesis, University of Notre Dame. Accessed April 14, 2021. https://curate.nd.edu/show/db78tb12q6h.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Barker, William T.. “Small Molecules That Synergize with Colistin</h1>.” 2020. Web. 14 Apr 2021.

Vancouver:

Barker WT. Small Molecules That Synergize with Colistin</h1>. [Internet] [Thesis]. University of Notre Dame; 2020. [cited 2021 Apr 14]. Available from: https://curate.nd.edu/show/db78tb12q6h.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Barker WT. Small Molecules That Synergize with Colistin</h1>. [Thesis]. University of Notre Dame; 2020. Available from: https://curate.nd.edu/show/db78tb12q6h

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cincinnati

20. Patchala, Jagadeesh. Data Mining Algorithms for Discovering Patterns in Text Collections.

Degree: PhD, Engineering and Applied Science: Computer Science and Engineering, 2016, University of Cincinnati

 Discovering meta-information from collections of text documents is becoming an important research area due to increasing demands for automated analysis of large text collections. This… (more)

Subjects/Keywords: Computer Science; Authorship Analysis; Biclustering; 3-clusters; Drug repurposing; Text mining; Data mining

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Patchala, J. (2016). Data Mining Algorithms for Discovering Patterns in Text Collections. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1458299372

Chicago Manual of Style (16th Edition):

Patchala, Jagadeesh. “Data Mining Algorithms for Discovering Patterns in Text Collections.” 2016. Doctoral Dissertation, University of Cincinnati. Accessed April 14, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1458299372.

MLA Handbook (7th Edition):

Patchala, Jagadeesh. “Data Mining Algorithms for Discovering Patterns in Text Collections.” 2016. Web. 14 Apr 2021.

Vancouver:

Patchala J. Data Mining Algorithms for Discovering Patterns in Text Collections. [Internet] [Doctoral dissertation]. University of Cincinnati; 2016. [cited 2021 Apr 14]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1458299372.

Council of Science Editors:

Patchala J. Data Mining Algorithms for Discovering Patterns in Text Collections. [Doctoral Dissertation]. University of Cincinnati; 2016. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1458299372

21. Marta Lopes Lima. Estudo do mecanismo de ação de fármacos em Leishmania: uma abordagem metabolômica não dirigida.

Degree: 2017, University of São Paulo

 A quimioterapia disponível para o tratamento das leishmanioses conta com um número reduzido de fármacos, com efeitos adversos severos e progressivo aumento de resistência. O… (more)

Subjects/Keywords: Antidepressivos; Fármacos; Leishmania; Metabolômica; Reposicionamento de fármacos; Antidepresants; Drug repurposing; Drugs; Leishmania; Metabolomics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lima, M. L. (2017). Estudo do mecanismo de ação de fármacos em Leishmania: uma abordagem metabolômica não dirigida. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/99/99131/tde-13112017-090743/

Chicago Manual of Style (16th Edition):

Lima, Marta Lopes. “Estudo do mecanismo de ação de fármacos em Leishmania: uma abordagem metabolômica não dirigida.” 2017. Doctoral Dissertation, University of São Paulo. Accessed April 14, 2021. http://www.teses.usp.br/teses/disponiveis/99/99131/tde-13112017-090743/.

MLA Handbook (7th Edition):

Lima, Marta Lopes. “Estudo do mecanismo de ação de fármacos em Leishmania: uma abordagem metabolômica não dirigida.” 2017. Web. 14 Apr 2021.

Vancouver:

Lima ML. Estudo do mecanismo de ação de fármacos em Leishmania: uma abordagem metabolômica não dirigida. [Internet] [Doctoral dissertation]. University of São Paulo; 2017. [cited 2021 Apr 14]. Available from: http://www.teses.usp.br/teses/disponiveis/99/99131/tde-13112017-090743/.

Council of Science Editors:

Lima ML. Estudo do mecanismo de ação de fármacos em Leishmania: uma abordagem metabolômica não dirigida. [Doctoral Dissertation]. University of São Paulo; 2017. Available from: http://www.teses.usp.br/teses/disponiveis/99/99131/tde-13112017-090743/


University of Illinois – Urbana-Champaign

22. Ostadhossein, Fatemeh. A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells.

Degree: MS, Bioengineering, 2015, University of Illinois – Urbana-Champaign

 Primary tumor extermination and conventional chemotherapy are proved to be inefficient in cancer therapy in that they preferentially abolish differentiated cells whilst leaving behind treatment… (more)

Subjects/Keywords: Cancer stem cell; STAT3 inhibition; Drug Delivery; Drug Repurposing; Carbon nanoparticles; Host guest chemistry; Cucurbitruil[6]; Niclosamide

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ostadhossein, F. (2015). A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells. (Thesis). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/89162

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ostadhossein, Fatemeh. “A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells.” 2015. Thesis, University of Illinois – Urbana-Champaign. Accessed April 14, 2021. http://hdl.handle.net/2142/89162.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ostadhossein, Fatemeh. “A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells.” 2015. Web. 14 Apr 2021.

Vancouver:

Ostadhossein F. A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells. [Internet] [Thesis]. University of Illinois – Urbana-Champaign; 2015. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2142/89162.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ostadhossein F. A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells. [Thesis]. University of Illinois – Urbana-Champaign; 2015. Available from: http://hdl.handle.net/2142/89162

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Kyoto University

23. SONI, SISWANTO. A drug repurposing study based on clinical big data for the treatment of interstitial lung disease .

Degree: 2020, Kyoto University

Subjects/Keywords: Drug repurposing; Drug repositioning; Interstitial lung disease; Amiodarone; Dabigatran

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

SONI, S. (2020). A drug repurposing study based on clinical big data for the treatment of interstitial lung disease . (Thesis). Kyoto University. Retrieved from http://hdl.handle.net/2433/259020

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

SONI, SISWANTO. “A drug repurposing study based on clinical big data for the treatment of interstitial lung disease .” 2020. Thesis, Kyoto University. Accessed April 14, 2021. http://hdl.handle.net/2433/259020.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

SONI, SISWANTO. “A drug repurposing study based on clinical big data for the treatment of interstitial lung disease .” 2020. Web. 14 Apr 2021.

Vancouver:

SONI S. A drug repurposing study based on clinical big data for the treatment of interstitial lung disease . [Internet] [Thesis]. Kyoto University; 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2433/259020.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

SONI S. A drug repurposing study based on clinical big data for the treatment of interstitial lung disease . [Thesis]. Kyoto University; 2020. Available from: http://hdl.handle.net/2433/259020

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cambridge

24. Rahman, Md Saifur. Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells.

Degree: PhD, 2020, University of Cambridge

 The store-operated calcium entry (SOCE) pathway is an important route for generating cytosolic Ca2+ signals that regulate a diverse array of biological processes. Abnormal SOCE… (more)

Subjects/Keywords: Store operated calcium entry; SOCE blockers; Drug repurposing; OPCs; OPCS differentiation; multiple sclerosis; SOCE in OPCs

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rahman, M. S. (2020). Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/304875

Chicago Manual of Style (16th Edition):

Rahman, Md Saifur. “Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells.” 2020. Doctoral Dissertation, University of Cambridge. Accessed April 14, 2021. https://www.repository.cam.ac.uk/handle/1810/304875.

MLA Handbook (7th Edition):

Rahman, Md Saifur. “Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells.” 2020. Web. 14 Apr 2021.

Vancouver:

Rahman MS. Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Apr 14]. Available from: https://www.repository.cam.ac.uk/handle/1810/304875.

Council of Science Editors:

Rahman MS. Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://www.repository.cam.ac.uk/handle/1810/304875

25. Yousfi, Hanane. Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals.

Degree: Docteur es, Maladies infectieuses, 2019, Aix Marseille Université

Les infections fongiques invasives constituent un sérieux problème de santé publique dans le monde ; cette situation se complique par la disponibilité d’un faible nombre… (more)

Subjects/Keywords: Résistance aux antimicrobiens; Antifongiques; Alternatives thérapeutiques; Repositionnement des médicaments; Antimicrobial-Resistance; Antifungals; Therapeutic alternatives; Drug-Repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yousfi, H. (2019). Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals. (Doctoral Dissertation). Aix Marseille Université. Retrieved from http://www.theses.fr/2019AIXM0234

Chicago Manual of Style (16th Edition):

Yousfi, Hanane. “Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals.” 2019. Doctoral Dissertation, Aix Marseille Université. Accessed April 14, 2021. http://www.theses.fr/2019AIXM0234.

MLA Handbook (7th Edition):

Yousfi, Hanane. “Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals.” 2019. Web. 14 Apr 2021.

Vancouver:

Yousfi H. Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals. [Internet] [Doctoral dissertation]. Aix Marseille Université 2019. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2019AIXM0234.

Council of Science Editors:

Yousfi H. Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals. [Doctoral Dissertation]. Aix Marseille Université 2019. Available from: http://www.theses.fr/2019AIXM0234


University of Sydney

26. El-Rashid, Mary. The use of drug repurposing to identify new treatment opportunities for kidney injury .

Degree: University of Sydney

 Aim: To determine the role of drug repurposing to treat kidney injury. Background: Acute kidney injury (AKI), is a major contributor to morbidity and mortality… (more)

Subjects/Keywords: AKI; CKD; colchicine; doxycycline; metformin; drug repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

El-Rashid, M. (n.d.). The use of drug repurposing to identify new treatment opportunities for kidney injury . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/22327

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

El-Rashid, Mary. “The use of drug repurposing to identify new treatment opportunities for kidney injury .” Thesis, University of Sydney. Accessed April 14, 2021. http://hdl.handle.net/2123/22327.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

El-Rashid, Mary. “The use of drug repurposing to identify new treatment opportunities for kidney injury .” Web. 14 Apr 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

El-Rashid M. The use of drug repurposing to identify new treatment opportunities for kidney injury . [Internet] [Thesis]. University of Sydney; [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2123/22327.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

El-Rashid M. The use of drug repurposing to identify new treatment opportunities for kidney injury . [Thesis]. University of Sydney; Available from: http://hdl.handle.net/2123/22327

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Purdue University

27. Thangamani, Shankar. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.

Degree: PhD, 2016, Purdue University

  Bacterial and fungal resistance to conventional antimicrobials is a burgeoning global health epidemic that necessitates urgent action. Even more alarming, the development of new… (more)

Subjects/Keywords: Biological sciences; Health and environmental sciences; Antimicrobial resistance; Approved drugs; Bacteria; Drug discovery; Fungi; Repurposing; Immunology and Infectious Disease; Microbiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thangamani, S. (2016). Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. (Doctoral Dissertation). Purdue University. Retrieved from https://docs.lib.purdue.edu/open_access_dissertations/1015

Chicago Manual of Style (16th Edition):

Thangamani, Shankar. “Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.” 2016. Doctoral Dissertation, Purdue University. Accessed April 14, 2021. https://docs.lib.purdue.edu/open_access_dissertations/1015.

MLA Handbook (7th Edition):

Thangamani, Shankar. “Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.” 2016. Web. 14 Apr 2021.

Vancouver:

Thangamani S. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. [Internet] [Doctoral dissertation]. Purdue University; 2016. [cited 2021 Apr 14]. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1015.

Council of Science Editors:

Thangamani S. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. [Doctoral Dissertation]. Purdue University; 2016. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1015


University of Toronto

28. Williams, Vanessa. Identification of Novel Therapeutic Approaches to the Progression of Chronic Kidney Disease.

Degree: PhD, 2020, University of Toronto

 Progression of chronic kidney disease (CKD) to renal failure is a substantial international public health problem. Existing treatments have limited effectiveness as they slow, but… (more)

Subjects/Keywords: Angiotensin-converting enzyme 2; Chronic kidney disease; Drug repurposing; Interstitial fibrosis; Lysine deacetylase; Proximal tubule cell; 0307

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Williams, V. (2020). Identification of Novel Therapeutic Approaches to the Progression of Chronic Kidney Disease. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/103336

Chicago Manual of Style (16th Edition):

Williams, Vanessa. “Identification of Novel Therapeutic Approaches to the Progression of Chronic Kidney Disease.” 2020. Doctoral Dissertation, University of Toronto. Accessed April 14, 2021. http://hdl.handle.net/1807/103336.

MLA Handbook (7th Edition):

Williams, Vanessa. “Identification of Novel Therapeutic Approaches to the Progression of Chronic Kidney Disease.” 2020. Web. 14 Apr 2021.

Vancouver:

Williams V. Identification of Novel Therapeutic Approaches to the Progression of Chronic Kidney Disease. [Internet] [Doctoral dissertation]. University of Toronto; 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1807/103336.

Council of Science Editors:

Williams V. Identification of Novel Therapeutic Approaches to the Progression of Chronic Kidney Disease. [Doctoral Dissertation]. University of Toronto; 2020. Available from: http://hdl.handle.net/1807/103336

29. Adriana Bezerra de Souza. Avaliação da eficácia in vitro ou in vivo da butenafina livre ou nanoencapsulada contra L. (L.) infantum e L. (L.) amazonensis.

Degree: 2019, University of São Paulo

 A leishmaniose se refere a doenças causadas por diferentes espécies de protozoários parasitos do gênero Leishmania, que ocorrem em 98 países, portanto, é um problema… (more)

Subjects/Keywords: Butenafina; Leishmania; Leishmaniose cutânea; Nanoencapsulamento; Reposicionamento de fármacos; Terapia; Butenafine; Cutaneous Leishmaniasis; Drug repurposing; Leishmania; Nanocarriers; Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Souza, A. B. d. (2019). Avaliação da eficácia in vitro ou in vivo da butenafina livre ou nanoencapsulada contra L. (L.) infantum e L. (L.) amazonensis. (Masters Thesis). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/5/5160/tde-29012020-134643/

Chicago Manual of Style (16th Edition):

Souza, Adriana Bezerra de. “Avaliação da eficácia in vitro ou in vivo da butenafina livre ou nanoencapsulada contra L. (L.) infantum e L. (L.) amazonensis.” 2019. Masters Thesis, University of São Paulo. Accessed April 14, 2021. http://www.teses.usp.br/teses/disponiveis/5/5160/tde-29012020-134643/.

MLA Handbook (7th Edition):

Souza, Adriana Bezerra de. “Avaliação da eficácia in vitro ou in vivo da butenafina livre ou nanoencapsulada contra L. (L.) infantum e L. (L.) amazonensis.” 2019. Web. 14 Apr 2021.

Vancouver:

Souza ABd. Avaliação da eficácia in vitro ou in vivo da butenafina livre ou nanoencapsulada contra L. (L.) infantum e L. (L.) amazonensis. [Internet] [Masters thesis]. University of São Paulo; 2019. [cited 2021 Apr 14]. Available from: http://www.teses.usp.br/teses/disponiveis/5/5160/tde-29012020-134643/.

Council of Science Editors:

Souza ABd. Avaliação da eficácia in vitro ou in vivo da butenafina livre ou nanoencapsulada contra L. (L.) infantum e L. (L.) amazonensis. [Masters Thesis]. University of São Paulo; 2019. Available from: http://www.teses.usp.br/teses/disponiveis/5/5160/tde-29012020-134643/


University of Vienna

30. Gurinova, Jana. Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates.

Degree: 2018, University of Vienna

 Seltene Erkrankungen betreffen weltweit über 400 Millionen Menschen. Sie werden über ihre Häufigkeit beziehungsweise ihre Seltenheit definiert, und daher zwangsläufig auch über eine geringe Zahl… (more)

Subjects/Keywords: 44.42 Pharmazeutische Chemie; 44.40 Pharmazie, Pharmazeutika; 44.48 Medizinische Genetik; seltene Erkrankungen / KNIME / Workflow / Data-Mining / Neupositionierung; orphan diseases / rare diseases / KNIME / workflow / data mining / drug repurposing / drug repositioning

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gurinova, J. (2018). Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates. (Thesis). University of Vienna. Retrieved from http://othes.univie.ac.at/55364/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gurinova, Jana. “Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates.” 2018. Thesis, University of Vienna. Accessed April 14, 2021. http://othes.univie.ac.at/55364/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gurinova, Jana. “Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates.” 2018. Web. 14 Apr 2021.

Vancouver:

Gurinova J. Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates. [Internet] [Thesis]. University of Vienna; 2018. [cited 2021 Apr 14]. Available from: http://othes.univie.ac.at/55364/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gurinova J. Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates. [Thesis]. University of Vienna; 2018. Available from: http://othes.univie.ac.at/55364/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2]

.